Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen

AIDS

Volumn 12, Issue 12, 1998, Pages 1483-1490

  Notermans, Daan W ^a,b   Goudsmit, Jaap ^a,b   Danner, Sven A ^b   De Wolf, Frank ^a   Perelson, Alan S ^c   Mittler, John ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

Biological models; Combination drug therapy; Dynamics; HIV 1; Lamivudine; Ritonavir; Zidovudine

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; LAMIVUDINE; RITONAVIR; ZIDOVUDINE;

ARTICLE; CELL POPULATION; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATHEMATICAL MODEL; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS LOAD;

ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV-1; HUMANS; LAMIVUDINE; MODELS, THEORETICAL; RITONAVIR; RNA, VIRAL; TREATMENT OUTCOME; VIRAL LOAD; ZIDOVUDINE;

EID: 0032552097     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199812000-00010     Document Type: Article

References (25)

1. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272:1167-1170.
2. Jurriaans S, van Gemen B, Weverling GJ, et al.: The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? Virology 1994, 204:223-233.
3. Hogervorst E, Jurriaans S, Wolf de F, et al.: Predictors for non- and slow progression in human immunodeficiency virus type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific, but not V3-specific antibody levels. J Infect Dis 1995, 171:811-821.
4. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al.: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995, 122:573-579.
5. Henrard DR, Phillips JF, Muenz LR, et al.: Natural history of HIV-1 cell-free viremia. JAMA 1995, 274:554-558.
6. Wolf de F, Spijkerman I, Schellekens PT, et al.: AIDS prognosis based on HIV-1 RNA CD4+ cell count and function: markers with reciprocal predictive value over time after seroconversion. AIDS 1997, 11:1799-1806.
7. Cavert W, Notermans DW, Staskus K, et al.: Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997, 276:960-964.
8. Notermans DW, Jurriaans S, de Wolf F, et al.: Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group. AIDS 1998, 12:167-173.
9. Perelson AS, Essunger P, Cao Y, et al.: Decay characteristics of HIV-1 infected compartments during combination therapy. Nature 1997, 387:188-191.
10. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
11. Wei X, Ghosh SK, Taylor ME, et al.: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995, 373:117-122.
12. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD: HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996, 271:1582-1586.
13. Klennerman P, Philliips RE, Rinaldo CR, et al.: Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proc Natl Acad Sci USA 1997, 93:15323-15328.
14. Feinberg MB, McLean AR: AIDS: decline and fall of immune surveillance? Curr Biol 1997, 7:R136-R140.
15. Pocock SJ, Simon R: Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975, 31:103-115.
16. Essunger P, Markowitz M, Ho DD, Perelson AS: Efficacy of drug combination and dosing regimen in antiviral therapy. International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication. St Petersburg, June 1997 [abstract 73].
17. Bonhoeffer S, May RM, Shaw GM, Nowak MA: Virus dynamics and drug-therapy. Proc Natl Acad Sci USA 1997, 94:6971-6976.
18. Wein LM, D'Amato RM, Perelson AS: Mathematical analysis of antiretroviral therapy aimed at HIV-1 eradication or maintenance of low viral loads. J Theor Biol 1998, 192:81-98.
19. Pakker NG, Notermans DW, de Boer RJ, et al.: Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation. Nat Med 1998, 4:208-224.
20. Mohri H, Bonhoeffer S, Monard S, Perelson AS, Ho DD: Rapid turnover of T-lymphocytes in SIV-infected Rhesus macaques. Science 1998, 279:1223-1227.
21. Chun TW, Stuyver L, Mizell SB, et al.: Presence of an inducible HIV-1 latent reservoir during highly-active antiretroviral therapy. Proc Natl Acad Sci USA 1997, 94:13193-19197.
22. Wong JK, Hezareh M, Gunthard HF, et al.: Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997, 278:1291-1295.
23. Finzi D, Hermankova M, Pierson T, et al.: Identification of a reservoir for HIV-1 in patients on highly-active antiretroviral therapy. Science 1997, 278:1295-1300.
24. Ogg CS, Jin X, Bonhoeffer S, et al.: Dynamics of HIV-specific cytotoxic T lymphocytes after combination antiretroviral therapy. Science 1998, 279:2103-2106.
25. Bonhoeffer S, Coffin JM, Nowak MA: Human immunodeficiency virus drug therapy and virus load. J Virol 1997, 71:3275-3278.